Concepts (204)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oils, Volatile | 7 | 2019 | 13 | 2.050 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 10 | 2019 | 83 | 1.610 |
Why?
|
| Anti-Bacterial Agents | 4 | 2025 | 432 | 1.390 |
Why?
|
| Caenorhabditis elegans | 3 | 2017 | 80 | 1.320 |
Why?
|
| Azo Compounds | 2 | 2021 | 17 | 1.190 |
Why?
|
| Sulfonylurea Compounds | 2 | 2017 | 17 | 1.010 |
Why?
|
| Clothing | 2 | 2016 | 9 | 0.990 |
Why?
|
| Thiazolidinediones | 2 | 2017 | 49 | 0.970 |
Why?
|
| Metformin | 2 | 2017 | 75 | 0.940 |
Why?
|
| Thiazoles | 1 | 2025 | 76 | 0.900 |
Why?
|
| Fatty Acids | 2 | 2016 | 134 | 0.900 |
Why?
|
| Chromatography, High Pressure Liquid | 6 | 2017 | 465 | 0.870 |
Why?
|
| Fungi | 5 | 2011 | 106 | 0.870 |
Why?
|
| Drug Design | 1 | 2025 | 186 | 0.830 |
Why?
|
| Antifungal Agents | 4 | 2011 | 169 | 0.810 |
Why?
|
| Antioxidants | 3 | 2012 | 443 | 0.790 |
Why?
|
| Carcinogens | 2 | 2021 | 126 | 0.780 |
Why?
|
| Monoterpenes | 3 | 2019 | 10 | 0.760 |
Why?
|
| Environmental Exposure | 2 | 2017 | 256 | 0.710 |
Why?
|
| Antinematodal Agents | 2 | 2013 | 5 | 0.680 |
Why?
|
| Textiles | 2 | 2021 | 7 | 0.670 |
Why?
|
| Coloring Agents | 2 | 2021 | 55 | 0.660 |
Why?
|
| Food Contamination | 2 | 2015 | 57 | 0.650 |
Why?
|
| Gram-Negative Bacteria | 3 | 2011 | 29 | 0.640 |
Why?
|
| Gram-Positive Bacteria | 3 | 2025 | 21 | 0.600 |
Why?
|
| Mentha spicata | 1 | 2019 | 1 | 0.600 |
Why?
|
| Spices | 2 | 2015 | 9 | 0.570 |
Why?
|
| Quorum Sensing | 2 | 2008 | 16 | 0.540 |
Why?
|
| Plant Extracts | 3 | 2012 | 302 | 0.530 |
Why?
|
| Simvastatin | 1 | 2017 | 29 | 0.530 |
Why?
|
| Lighting | 1 | 2017 | 12 | 0.520 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2017 | 104 | 0.510 |
Why?
|
| Antineoplastic Agents | 4 | 2025 | 1019 | 0.500 |
Why?
|
| Mutagens | 2 | 2015 | 74 | 0.500 |
Why?
|
| Environmental Monitoring | 3 | 2016 | 230 | 0.500 |
Why?
|
| Glipizide | 1 | 2016 | 5 | 0.500 |
Why?
|
| Carbamates | 1 | 2016 | 13 | 0.490 |
Why?
|
| Guanidines | 1 | 2016 | 17 | 0.490 |
Why?
|
| Amines | 1 | 2016 | 41 | 0.480 |
Why?
|
| Apiaceae | 1 | 2015 | 3 | 0.480 |
Why?
|
| Plant Oils | 2 | 2014 | 20 | 0.480 |
Why?
|
| Light | 1 | 2017 | 185 | 0.480 |
Why?
|
| Terpenes | 2 | 2013 | 30 | 0.470 |
Why?
|
| Piperidines | 1 | 2016 | 83 | 0.470 |
Why?
|
| Metals | 1 | 2016 | 114 | 0.470 |
Why?
|
| Benzimidazoles | 2 | 2025 | 43 | 0.460 |
Why?
|
| Triglycerides | 1 | 2015 | 147 | 0.460 |
Why?
|
| Models, Theoretical | 1 | 2017 | 232 | 0.450 |
Why?
|
| Glycosides | 2 | 2025 | 23 | 0.450 |
Why?
|
| Foeniculum | 2 | 2014 | 2 | 0.450 |
Why?
|
| Fruit | 2 | 2015 | 178 | 0.440 |
Why?
|
| Structure-Activity Relationship | 5 | 2025 | 506 | 0.440 |
Why?
|
| Triazoles | 2 | 2025 | 102 | 0.440 |
Why?
|
| Tea | 1 | 2015 | 46 | 0.440 |
Why?
|
| Chromatography, Liquid | 1 | 2015 | 182 | 0.430 |
Why?
|
| Selenium | 1 | 2016 | 155 | 0.430 |
Why?
|
| Arsenic | 1 | 2016 | 155 | 0.430 |
Why?
|
| Pyridines | 2 | 2025 | 139 | 0.420 |
Why?
|
| Molecular Structure | 5 | 2025 | 570 | 0.420 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 184 | 0.420 |
Why?
|
| Coffee | 1 | 2014 | 20 | 0.410 |
Why?
|
| Trace Elements | 2 | 2016 | 35 | 0.400 |
Why?
|
| Seeds | 2 | 2015 | 46 | 0.390 |
Why?
|
| Charcoal | 1 | 2013 | 7 | 0.390 |
Why?
|
| Smoke | 1 | 2013 | 42 | 0.380 |
Why?
|
| Microbial Sensitivity Tests | 3 | 2025 | 245 | 0.360 |
Why?
|
| Environmental Pollutants | 1 | 2014 | 201 | 0.340 |
Why?
|
| Rosa | 1 | 2011 | 2 | 0.340 |
Why?
|
| Pesticide Residues | 1 | 2011 | 8 | 0.340 |
Why?
|
| Flowers | 1 | 2011 | 20 | 0.340 |
Why?
|
| Hair | 1 | 2011 | 38 | 0.340 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2011 | 21 | 0.330 |
Why?
|
| Chromatography, Supercritical Fluid | 2 | 2014 | 3 | 0.330 |
Why?
|
| Food Analysis | 2 | 2015 | 34 | 0.330 |
Why?
|
| Drug Screening Assays, Antitumor | 3 | 2025 | 157 | 0.320 |
Why?
|
| Anti-Infective Agents | 1 | 2011 | 75 | 0.320 |
Why?
|
| Quantitative Structure-Activity Relationship | 2 | 2008 | 110 | 0.320 |
Why?
|
| Free Radical Scavengers | 1 | 2010 | 64 | 0.310 |
Why?
|
| Polyesters | 2 | 2021 | 28 | 0.300 |
Why?
|
| Biofilms | 2 | 2008 | 184 | 0.300 |
Why?
|
| Pest Control | 1 | 2008 | 4 | 0.290 |
Why?
|
| Nematoda | 1 | 2008 | 11 | 0.290 |
Why?
|
| Organic Chemicals | 1 | 2008 | 36 | 0.290 |
Why?
|
| Acyl-Butyrolactones | 1 | 2008 | 2 | 0.280 |
Why?
|
| Crops, Agricultural | 1 | 2008 | 36 | 0.280 |
Why?
|
| Fabaceae | 1 | 2008 | 30 | 0.280 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2025 | 1124 | 0.280 |
Why?
|
| Water Supply | 1 | 2008 | 60 | 0.270 |
Why?
|
| Humans | 18 | 2025 | 43102 | 0.270 |
Why?
|
| Bacteria | 1 | 2011 | 293 | 0.270 |
Why?
|
| Water Microbiology | 1 | 2008 | 81 | 0.270 |
Why?
|
| Farnesol | 1 | 2007 | 5 | 0.260 |
Why?
|
| Metals, Heavy | 1 | 2008 | 71 | 0.260 |
Why?
|
| Cell Proliferation | 4 | 2025 | 1455 | 0.250 |
Why?
|
| Artemisia | 1 | 2006 | 4 | 0.240 |
Why?
|
| Smoking | 1 | 2013 | 1024 | 0.240 |
Why?
|
| Coronary Sinus | 1 | 2025 | 2 | 0.230 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2025 | 27 | 0.230 |
Why?
|
| Glycoconjugates | 1 | 2025 | 6 | 0.230 |
Why?
|
| Acetaminophen | 1 | 2025 | 30 | 0.230 |
Why?
|
| Angina Pectoris | 1 | 2025 | 20 | 0.230 |
Why?
|
| Neuralgia, Postherpetic | 1 | 2025 | 3 | 0.230 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2025 | 2 | 0.230 |
Why?
|
| Nitro Compounds | 1 | 2025 | 34 | 0.230 |
Why?
|
| Anticonvulsants | 1 | 2025 | 40 | 0.230 |
Why?
|
| Essential Tremor | 1 | 2025 | 3 | 0.230 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2025 | 14 | 0.230 |
Why?
|
| Atrazine | 1 | 2005 | 8 | 0.230 |
Why?
|
| Cyclooxygenase 2 | 1 | 2025 | 107 | 0.230 |
Why?
|
| Nitriles | 1 | 2025 | 81 | 0.220 |
Why?
|
| Pyridones | 1 | 2025 | 50 | 0.220 |
Why?
|
| Cerebellum | 1 | 2025 | 79 | 0.220 |
Why?
|
| Animals | 6 | 2025 | 16992 | 0.220 |
Why?
|
| Immunosuppressive Agents | 1 | 2025 | 94 | 0.220 |
Why?
|
| Herbicides | 1 | 2005 | 43 | 0.220 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2025 | 159 | 0.210 |
Why?
|
| Pilonidal Sinus | 1 | 2023 | 1 | 0.210 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 458 | 0.200 |
Why?
|
| Computer Simulation | 1 | 2025 | 408 | 0.200 |
Why?
|
| Lipid Metabolism | 2 | 2016 | 148 | 0.190 |
Why?
|
| Sepsis | 1 | 2023 | 90 | 0.190 |
Why?
|
| Biological Assay | 2 | 2013 | 63 | 0.170 |
Why?
|
| Treatment Outcome | 4 | 2025 | 1604 | 0.170 |
Why?
|
| Chromatography, Thin Layer | 2 | 2010 | 39 | 0.150 |
Why?
|
| Food Handling | 2 | 2012 | 35 | 0.150 |
Why?
|
| Oxidative Stress | 2 | 2017 | 1003 | 0.140 |
Why?
|
| Reproducibility of Results | 2 | 2023 | 1081 | 0.140 |
Why?
|
| Cell Line, Tumor | 4 | 2025 | 2676 | 0.140 |
Why?
|
| Chemistry, Physical | 2 | 2008 | 50 | 0.140 |
Why?
|
| Dosage Forms | 1 | 2017 | 4 | 0.140 |
Why?
|
| Chemical Phenomena | 2 | 2008 | 56 | 0.130 |
Why?
|
| Static Electricity | 2 | 2008 | 86 | 0.130 |
Why?
|
| Growth and Development | 1 | 2017 | 9 | 0.130 |
Why?
|
| Limit of Detection | 1 | 2017 | 94 | 0.130 |
Why?
|
| Nylons | 1 | 2016 | 2 | 0.130 |
Why?
|
| Cotton Fiber | 1 | 2016 | 5 | 0.130 |
Why?
|
| Drug Combinations | 1 | 2017 | 104 | 0.130 |
Why?
|
| Models, Chemical | 2 | 2008 | 204 | 0.120 |
Why?
|
| Drug Contamination | 1 | 2016 | 11 | 0.120 |
Why?
|
| Larva | 1 | 2017 | 133 | 0.120 |
Why?
|
| Predictive Value of Tests | 2 | 2008 | 440 | 0.120 |
Why?
|
| Evaluation Studies as Topic | 1 | 2016 | 62 | 0.120 |
Why?
|
| Linear Models | 1 | 2017 | 317 | 0.120 |
Why?
|
| Female | 4 | 2025 | 24698 | 0.110 |
Why?
|
| Skin | 1 | 2016 | 187 | 0.110 |
Why?
|
| Chrysenes | 1 | 2015 | 5 | 0.110 |
Why?
|
| Mass Spectrometry | 1 | 2016 | 280 | 0.110 |
Why?
|
| Fluorenes | 1 | 2015 | 26 | 0.110 |
Why?
|
| Fluorescence | 1 | 2015 | 118 | 0.110 |
Why?
|
| Texas | 2 | 2008 | 457 | 0.110 |
Why?
|
| Distillation | 1 | 2014 | 3 | 0.110 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 532 | 0.100 |
Why?
|
| Benzo(a)pyrene | 1 | 2015 | 128 | 0.100 |
Why?
|
| Myrtaceae | 1 | 2012 | 1 | 0.100 |
Why?
|
| Thymol | 1 | 2012 | 2 | 0.100 |
Why?
|
| Lamiaceae | 1 | 2012 | 3 | 0.100 |
Why?
|
| Picrates | 1 | 2012 | 7 | 0.100 |
Why?
|
| Eugenol | 1 | 2012 | 6 | 0.100 |
Why?
|
| Biphenyl Compounds | 1 | 2012 | 53 | 0.090 |
Why?
|
| Eye Infections, Fungal | 1 | 2010 | 2 | 0.080 |
Why?
|
| Keratitis | 1 | 2010 | 2 | 0.080 |
Why?
|
| Amphotericin B | 1 | 2010 | 25 | 0.080 |
Why?
|
| United States | 2 | 2015 | 5205 | 0.080 |
Why?
|
| Fluconazole | 1 | 2010 | 41 | 0.080 |
Why?
|
| Dietary Supplements | 1 | 2012 | 213 | 0.080 |
Why?
|
| Time Factors | 2 | 2025 | 1857 | 0.080 |
Why?
|
| Microwaves | 2 | 2014 | 29 | 0.080 |
Why?
|
| Noxae | 1 | 2008 | 1 | 0.070 |
Why?
|
| Hydrocarbons, Brominated | 1 | 2008 | 4 | 0.070 |
Why?
|
| United States Environmental Protection Agency | 1 | 2008 | 6 | 0.070 |
Why?
|
| United States Food and Drug Administration | 1 | 2008 | 29 | 0.070 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2008 | 134 | 0.060 |
Why?
|
| Chromatography, Gas | 1 | 2006 | 15 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2011 | 1766 | 0.060 |
Why?
|
| Caco-2 Cells | 1 | 2025 | 64 | 0.060 |
Why?
|
| HCT116 Cells | 1 | 2025 | 40 | 0.060 |
Why?
|
| Exercise Tolerance | 1 | 2025 | 22 | 0.060 |
Why?
|
| Hep G2 Cells | 1 | 2025 | 63 | 0.060 |
Why?
|
| Fumarates | 1 | 2025 | 11 | 0.060 |
Why?
|
| Seizures | 1 | 2025 | 79 | 0.060 |
Why?
|
| Middle Aged | 3 | 2025 | 12222 | 0.060 |
Why?
|
| Recovery of Function | 1 | 2025 | 107 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2024 | 32 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2006 | 301 | 0.050 |
Why?
|
| Solvents | 1 | 2005 | 113 | 0.050 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2025 | 188 | 0.050 |
Why?
|
| Observer Variation | 1 | 2023 | 59 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2025 | 375 | 0.050 |
Why?
|
| Rats | 1 | 2011 | 3735 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 587 | 0.040 |
Why?
|
| Male | 2 | 2025 | 23409 | 0.040 |
Why?
|
| Apoptosis | 1 | 2025 | 1568 | 0.030 |
Why?
|
| Adult | 2 | 2011 | 13872 | 0.030 |
Why?
|
| Aged | 2 | 2025 | 8214 | 0.030 |
Why?
|
| Risk Factors | 1 | 2025 | 3994 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2023 | 2544 | 0.030 |
Why?
|
| Corneal Ulcer | 1 | 2010 | 1 | 0.020 |
Why?
|
| Conjunctiva | 1 | 2010 | 6 | 0.020 |
Why?
|
| Injections | 1 | 2010 | 42 | 0.020 |
Why?
|
| Ophthalmic Solutions | 1 | 2010 | 18 | 0.020 |
Why?
|
| Candida | 1 | 2010 | 42 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 234 | 0.020 |
Why?
|
| Young Adult | 1 | 2010 | 5080 | 0.010 |
Why?
|
| Adolescent | 1 | 2010 | 6081 | 0.010 |
Why?
|